Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo

被引:13
作者
Miyata, Y
Ashida, S
Nakamura, T
Mochizuki, Y
Koga, S
Kanetake, H
Shuin, T
Kanda, S
机构
[1] Nagasaki Univ, Grad Sch Med Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan
[2] Kochi Med Sch, Dept Urol, Kochi, Japan
[3] Nagasaki Univ, Dept Urol, Grad Sch Med Sci, Nagasaki 852, Japan
基金
日本学术振兴会;
关键词
hepatocyte growth factor; renal cell carcinoma; receptor tyrosine kinase; overexpression; PI-3; kinase; vascular endothelial growth factor; angiogenesis;
D O I
10.1016/S0006-291X(03)00281-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the role of increased expression of HGFR kinase in in vivo growth of renal carcinoma. Human renal carcinoma cell line, ACHN cells, was transfected with plasmid encoding wild-type HGFR gene to generate cell lines with increased HGFR protein. ACHN cells with elevated HGFR expression, denoted clones 8 and 10, respectively, showed higher basal kinase activities of HGFR and PI3-kinase than those of empty-vector (mock)-transfected cells. Clone 8 and 10 cells grew similar to mock cells in culture. In mice, tumors of these clones grew more rapidly than those of mock cells. Microvessel density of clone 8 or 10 tumors was higher than that of mock tumors. Clone 8 and 10 cells secreted vascular endothelial growth factor-A (VEGF-A) more than mock cells and the secretion was PI3-kinase inhibitor, LY294002-sensitive. Anti-VEGF-A neutralizing antibody significantly inhibited tumor growth of clones 8 and 10 in mice. These results indicate for the first time that overexpression of HGFR tyrosine kinase in renal carcinoma cells participates in rapid tumor growth in vivo. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:892 / 897
页数:6
相关论文
共 40 条
[1]  
Alimov A, 1999, ANTICANCER RES, V19, P3841
[2]   Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor [J].
Antonyak, MA ;
Moscatello, DK ;
Wong, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2817-2822
[3]  
Ashida S, 2000, CLIN CANCER RES, V6, P3817
[4]   Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture [J].
Bergström, JD ;
Hermansson, A ;
de Ståhl, TD ;
Heldin, NE .
BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) :650-656
[5]   PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis [J].
Besson, A ;
Robbins, SM ;
Yong, VW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03) :605-611
[6]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[7]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[8]   The HGF receptor family: Unconventional signal transducers for invasive cell growth [J].
Comoglio, PM ;
Boccaccio, C .
GENES TO CELLS, 1996, 1 (04) :347-354
[9]  
DIRENZO MF, 1995, CANCER RES, V55, P1129
[10]   OVEREXPRESSION OF THE MET HGF RECEPTOR IN OVARIAN-CANCER [J].
DIRENZO, MF ;
OLIVERO, M ;
KATSAROS, D ;
CREPALDI, T ;
GAGLIA, P ;
ZOLA, P ;
SISMONDI, P ;
COMOGLIO, PM .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (05) :658-662